ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine

ClinicalTrials.gov ID: NCT03836040

Public ClinicalTrials.gov record NCT03836040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 4:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])

Study identification

NCT ID
NCT03836040
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
457 participants

Conditions and interventions

Conditions

Interventions

  • Erenumab Dose 1 Drug
  • Erenumab Dose 2 Drug
  • Erenumab Dose 3 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2019
Primary completion
Nov 18, 2025
Completion
Nov 14, 2026
Last update posted
Dec 22, 2025

2019 – 2026

United States locations

U.S. sites
38
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Paradigm Clinical Research Center Inc San Diego California 92108
Childrens Hospital Colorado Aurora Colorado 80045
Colorado Springs Neurological Associates Colorado Springs Colorado 80907
New England Institute for Clinical Research Stamford Connecticut 06905
Childrens National Health System Washington D.C. District of Columbia 20010
Northwest Florida Clinical Research Group Limited Liability Company Gulf Breeze Florida 32561
Nicklaus Childrens Hospital Miami Florida 33155
Pediatric Epilepsy and Neurology Specialists Tampa Florida 33609
TrueBlue Clinical Research Tampa Florida 33612
Premiere Research Institute West Palm Beach Florida 33407
Rare Disease Research Center Pediatrics Atlanta Georgia 30329
CenExel iResearch, LLC Savannah Georgia 31405
Northwestern University Chicago Illinois 60611
Chicago Headache Center and Research Institute Chicago Illinois 60657
Josephson Wallack Munshower Neurology Indianapolis Indiana 46256
University of Maryland, Baltimore Baltimore Maryland 21201
New England Regional Headache Center Inc Worcester Massachusetts 14226
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104
Clinical Research Institute Inc Minneapolis Minnesota 55402
Childrens Mercy Hospital and Clinics Kansas City Missouri 64108
Mercy Research St Louis Missouri 63141
Velocity Clinical Research, Inc Grand Island Nebraska 68803
Dent Neurosciences Research Center Amherst New York 14226
Modern Migraine MD New York New York 10001
Columbia University Irving Medical Center New York New York 10032
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45229
Cleveland Clinic Foundation Cleveland Ohio 44195
Nationwide Childrens Hospital Columbus Ohio 43205
Oregon Health and Science University Portland Oregon 97239
Childrens Hospital of Philadelphia Philadelphia Pennsylvania 19104
Preferred Primary Care Physicians, Inc Pittsburgh Pennsylvania 15236
Palmetto Gastroenterology Clinical Research, LLC Summerville South Carolina 29486
Child Neurology Consultants of Austin Austin Texas 78757
Helios Clinical Research Inc Burleson Texas 76028
Stryde Consulting LLC Frisco Texas 75033
Childrens Specialty Group Norfolk Virginia 23507
Vaught Neurological Services Crab Orchard West Virginia 25827
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03836040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03836040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →